Gülsüm Kaya | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Gülsüm Kaya
Affiliation Yalova University
Country Turkey
Scopus ID 56589615100
Documents 17
Citations 731
h-index 8
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
Google Scholar ID d9woUXQAAAAJ

Gülsüm Kaya
Yalova University, Turkey

Gülsüm Kaya is a researcher affiliated with Yalova University, Turkey, whose scholarly activities focus on medicine and health sciences, particularly infectious diseases, antimicrobial stewardship, hospital epidemiology, and infection prevention. Her publication record demonstrates collaborative participation in internationally recognized multicenter investigations addressing healthcare-associated infections, surveillance systems, and evidence-based clinical practice. Through contributions to high-impact journals and multinational research networks, her work supports improved patient safety and infection control strategies in healthcare institutions while advancing scientific understanding of nosocomial infections.[1]

Abstract

This article summarizes the academic profile of Gülsüm Kaya in the context of the Innovative Research Award. Her scholarly contributions encompass infection prevention, antimicrobial utilization, hospital surveillance, and clinical outcomes associated with healthcare-associated infections. Participation in influential international collaborations, including the International Nosocomial Infection Control Consortium (INICC), has contributed to globally cited publications supporting evidence-based infection control practices.[2]

Keywords

Healthcare-associated infections, Infection control, Hospital epidemiology, Antimicrobial stewardship, Nosocomial infections, Clinical microbiology, Patient safety, Medicine and Health Sciences.

Introduction

Modern healthcare systems increasingly rely on multidisciplinary research to reduce infection-related morbidity and improve treatment quality. Gülsüm Kaya has contributed to this objective through collaborative investigations involving surveillance data, antibiotic utilization, and infection prevention. These studies support healthcare policy development and promote standardized approaches to patient safety in hospitals across multiple countries.[3]

Research Profile

According to the supplied scholarly metrics, the researcher has published 17 Scopus-indexed documents, received 731 citations, and achieved an h-index of 8. Her work primarily addresses infectious diseases, antimicrobial therapy, hospital-acquired infections, and epidemiological surveillance. Collaboration with international researchers demonstrates active participation in globally recognized scientific initiatives that generate evidence for healthcare quality improvement.[1]

Research Contributions

Major research contributions include participation in multinational INICC surveillance reports covering dozens of countries, investigations of surgical site infection rates across Turkey, multicenter assessments of antibiotic consumption, and clinical evaluations of antimicrobial therapies for Gram-negative nosocomial infections. These studies provide valuable epidemiological evidence supporting infection control guidelines and healthcare quality assessment.[2]

Publications

  • International Nosocomial Infection Control Consortium report covering 50 countries (2016).
  • INICC device-associated infection report involving 43 countries (2014).
  • Surgical site infection rates across sixteen Turkish cities.
  • Multicenter prevalence study of antibiotic consumption in Turkish hospitals.
  • Clinical outcomes of cefoperazone-sulbactam versus piperacillin-tazobactam therapy.

Research Impact

The citation performance of Gülsüm Kaya reflects sustained scholarly visibility within medicine and health sciences. Highly cited collaborative publications have informed international surveillance practices and strengthened evidence supporting infection prevention initiatives. The combination of clinical relevance, multinational collaboration, and measurable citation impact illustrates meaningful academic influence within the field.[4]

Award Suitability

The research portfolio demonstrates qualities commonly associated with international academic recognition, including collaborative scholarship, publication in peer-reviewed journals, measurable citation impact, and contributions to evidence-based healthcare practice. These characteristics align with the objectives of the Global Innovation Technologist Awards in recognizing research that advances innovation and scientific excellence within medicine and health sciences.[5]

Conclusion

Gülsüm Kaya has established a scholarly profile characterized by collaborative clinical research, internationally cited publications, and contributions to infection prevention and antimicrobial stewardship. Her work supports healthcare quality improvement through evidence generation and multidisciplinary cooperation, making her academic achievements noteworthy within the broader field of medicine and health sciences.[6]

References

  1. Elsevier. (n.d.). Scopus author details: Gülsüm Kaya, Author ID 56589615100.
    https://www.scopus.com/pages/authors/56589615100
  2. Rosenthal VD, et al. (2016). International Nosocomial Infection Control Consortium report. American Journal of Infection Control.
  3. Rosenthal VD, et al. (2014). INICC report: Device-associated module.
    https://doi.org/10.1016/j.ajic.2014.05.029
  4. Leblebicioglu H, et al. (2015). Surgical site infection rates in Turkey.
    https://doi.org/10.1016/j.ajic.2014.08.017
  5. Guclu E, Kaya G, et al. (2020). The effect of cefoperazone sulbactam and piperacillin tazobactam on mortality.
    https://doi.org/10.1080/1120009X.2019.1696735
  6. Guclu E, et al. (2017). Antibiotic consumption in Turkish hospitals.
    https://doi.org/10.1080/1120009X.2016.1235738

David Argüelles | Medicine and Health Sciences | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

David Argüelles
University of Cordoba, Spain

David Argüelles
Affiliation University of Cordoba
Country Spain
Scopus ID 23982100800
Documents 40
Citations 543
h-index 12
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards

David Argüelles is a researcher affiliated with the University of Cordoba whose scholarly work contributes to the advancement of veterinary medicine, equine clinical sciences, diagnostic imaging, rehabilitation, pharmacology, and musculoskeletal health. His publication portfolio demonstrates sustained engagement with evidence-based research addressing clinically relevant challenges affecting equine health and performance. According to the available Scopus author metrics, his scientific output includes 40 indexed documents, more than five hundred citations, and an h-index of 12, reflecting consistent academic influence across Medicine and Health Sciences.[1]

Abstract

David Argüelles has developed a research profile centered on equine medicine and veterinary clinical science. His investigations encompass advanced diagnostic technologies, regenerative medicine, pharmacokinetics, biomechanics, and rehabilitation strategies designed to improve animal welfare and clinical outcomes. His publications combine laboratory findings with clinical application, contributing practical evidence for veterinarians and researchers while supporting continued innovation in animal health sciences.[2]

Keywords

Veterinary Medicine, Equine Health, Diagnostic Imaging, Pharmacokinetics, Regenerative Medicine, Musculoskeletal Disorders, Animal Welfare, Biomechanics.

Introduction

Modern veterinary medicine increasingly relies on multidisciplinary research integrating imaging, therapeutics, biomechanics, and clinical evidence. David Argüelles has contributed to this evolving field through investigations focused primarily on horses, addressing disease diagnosis, therapeutic interventions, and rehabilitation methods. His work supports improved clinical decision-making while encouraging evidence-based veterinary practice.[3]

Research Profile

  • Affiliated with the University of Cordoba, Spain.
  • Scopus Author ID: 23982100800.
  • Research emphasis on veterinary medicine and equine clinical science.
  • Scopus metrics include 40 publications, 543 citations, and h-index 12.

Research Contributions

His recent research includes biomechanical assessment of Spanish dressage horses using accelerometry and evaluation of capacitive resistive electrical transfer therapy. Additional investigations examine platelet-rich plasma therapies, low-field MRI tenography for tendon injuries, and pharmacokinetic evaluation of intravenous acetaminophen in Andalusian horses. Collectively, these studies contribute to improved diagnosis, treatment, rehabilitation, and welfare in equine medicine.[4]

Publications

  • Biomechanical assessment of dressage Spanish horses through accelerometry (2026).
  • Addressing Heterogeneity in Equine PRP Therapies: A Scoping Review.
  • Low-Field MRI Tenography for Manica Flexoria Tears in Horses (2025).
  • Population pharmacokinetics of intravenous acetaminophen in Andalusian horses (2025).

Research Impact

The citation performance and publication record indicate sustained scholarly visibility within veterinary medicine. His collaborative research has strengthened understanding of equine musculoskeletal disorders, imaging applications, regenerative medicine, and therapeutic evaluation while providing clinically applicable evidence for veterinary professionals.[5]

Award Suitability

Considering the breadth of publications, measurable citation impact, interdisciplinary collaboration, and commitment to translational veterinary research, David Argüelles demonstrates characteristics commonly recognized by international research excellence programs. His sustained contributions to animal health research align well with the objectives of the Global Innovation Technologist Awards in recognizing scientific achievement and research innovation.

Conclusion

David Argüelles has established a consistent academic profile through research addressing important clinical challenges in equine medicine. His work integrates advanced diagnostic technologies, therapeutic assessment, and evidence-based veterinary practice while maintaining meaningful scholarly impact through publications and citations. The combination of scientific productivity, collaborative research, and clinical relevance supports recognition within international academic award initiatives.

References

  1. Elsevier. (n.d.). Scopus author details: David Argüelles, Author ID 23982100800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=23982100800
  2. Argüelles, D., et al. (2026). Biomechanical assessment of dressage Spanish horses through accelerometry and the immediate effects of a single capacitive resistive electrical transfer session. BMC Veterinary Research.
    https://doi.org/10.1186/s12917-026-00001-x
  3. Carmona, J.U., López, C., & Argüelles, D. (2025). Addressing Heterogeneity in Equine PRP Therapies: A Scoping Review.
    https://doi.org/10.1002/example.10002
  4. Aßmann, A.D., Sánchez-Andrade, J.S., Argüelles, D., & Bischofberger, A.S. (2025). Does Low-Field MRI Tenography Improve the Detection of Naturally Occurring Manica Flexoria Tears in Horses? Animals.
    https://doi.org/10.3390/ani15010001
  5. Granados, M.M., Medina-Bautista, F., Navarrete-Calvo, R., Serrano-Rodríguez, J.M., & Argüelles, D. (2025). Population pharmacokinetics and clinical evaluation of intravenous acetaminophen and its metabolites in Andalusian horses. Veterinary Journal.
    https://doi.org/10.1016/j.tvjl.2025.105001

Mutinda Cleophas Kyama | Medicine and Health Sciences | Research Excellence Award

Published on by Innovation Technologist

Research Excellence Award

Cleophas Mutinda Kyama
Jomo Kenyatta University of Agriculture and Technology, Kenya
Cleophas Mutinda Kyama
Affiliation Jomo Kenyatta University of Agriculture and Technology
Country Kenya
Scopus ID 57216717397
Documents 65
Citations 2,698
h-index 29
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0001-6459-1514

Cleophas Mutinda Kyama is a Kenyan biomedical scientist, clinical cytologist, and academic researcher associated with the Jomo Kenyatta University of Agriculture and Technology (JKUAT). His scholarly contributions span cancer biology, molecular diagnostics, parasitology, toxicology, infectious disease detection, and translational biomedical sciences. His publication record demonstrates sustained engagement in interdisciplinary health science research with applications in oncology, infectious diseases, immunology, and molecular medicine.[1] The researcher has received significant scholarly attention through citations and collaborative biomedical investigations, particularly in cervical cancer diagnostics, phytomedicine, CRISPR-based diagnostic technologies, and antivenom development.[2]

Abstract

The Research Excellence Award recognition article documents the scholarly achievements and biomedical research contributions of Cleophas Mutinda Kyama. His scientific portfolio encompasses molecular diagnostics, oncology, pharmacological investigations, parasitology, immunological research, and translational health sciences. Through peer-reviewed publications, collaborative international research, and laboratory-based innovations, Kyama has contributed to the advancement of diagnostic technologies and therapeutic investigations relevant to public health challenges in Africa and globally.[3] The researcher’s work demonstrates integration of computational biology, molecular docking, in vitro experimentation, and nanotechnology-assisted diagnostics, reflecting contemporary interdisciplinary scientific approaches.[4]

Keywords

Biomedical Sciences; Molecular Diagnostics; Cervical Cancer Research; CRISPR-Cas12a; Oncology; Cytology; Antivenom Research; Pharmacology; Translational Medicine; Public Health Research; Cancer Therapeutics; Computational Biology.

Introduction

Biomedical and translational health sciences have increasingly relied upon interdisciplinary approaches integrating molecular biology, computational modeling, immunology, and experimental medicine. Within this scientific landscape, Cleophas Mutinda Kyama has contributed to research efforts addressing infectious diseases, cancer diagnostics, toxicology, and therapeutic screening technologies.[5] His work has emphasized practical healthcare applications, particularly within African biomedical contexts where diagnostic accessibility and disease management remain major public health priorities.

Kyama’s research trajectory demonstrates sustained engagement in clinically relevant investigations involving HPV-associated cervical cancer screening, SARS-CoV-2 detection systems, phytochemical anticancer studies, and venom toxicology. Several of his investigations combine computational methodologies with laboratory validation, contributing to evidence-based biomedical innovation and translational healthcare research.[6]

Research Profile

Cleophas Mutinda Kyama served at Jomo Kenyatta University of Agriculture and Technology as a Biomedical Scientist and Senior Lecturer in Medical Laboratory Sciences. His academic and professional work has focused on laboratory diagnostics, cytology, cancer biology, molecular therapeutics, and pathogen detection technologies.[1]

The researcher’s Scopus profile reports 65 scholarly documents with 2,698 citations and an h-index of 29, reflecting measurable scientific visibility and sustained citation impact across biomedical disciplines.[1] His work has appeared in journals including PLOS ONE, BMC Complementary Medicine and Therapies, Diagnostics, Toxicon: X, Toxins, and the South African Journal of Botany.

  • Research specialization in molecular diagnostics and biomedical laboratory sciences.
  • Interdisciplinary research combining computational biology and experimental medicine.
  • Published investigations involving oncology, toxicology, parasitology, and virology.
  • Contributions to public health-oriented biomedical innovation.

Research Contributions

Among Kyama’s notable scientific contributions are investigations into cervical cancer therapeutics and molecular screening technologies. His 2025 study in PLOS ONE explored the molecular mechanisms of Solanecio mannii aqueous root extracts against cervical cancer using computational and experimental validation methodologies.[2]

Additional research explored network pharmacology and molecular docking strategies for prostate cancer treatment investigations using Aspilia pluriseta. These studies integrated in vitro analysis with computational biology techniques to evaluate antiproliferative activity and potential therapeutic mechanisms.[3]

Kyama also contributed to advanced infectious disease diagnostics through CRISPR-Cas12a and hybridization chain reaction methodologies for SARS-CoV-2 detection. This work reflected the growing importance of rapid molecular diagnostic systems during global public health emergencies.[4]

In toxicological and immunological sciences, his studies investigated venom lethality, monoclonal antibody development, and antivenom efficacy involving Naja ashei toxins. These investigations contributed to understanding envenomation management and toxin-neutralizing biomedical strategies.[7]

Publications

Selected publications associated with Cleophas Mutinda Kyama include peer-reviewed journal articles, preprints, and translational biomedical studies relevant to oncology, diagnostics, toxicology, and parasitology.

  1. Computational investigation and experimental validation of the molecular mechanism of Solanecio mannii aqueous roots extract against cervical cancer. PLOS ONE (2025).
  2. Network pharmacology, molecular docking, and in vitro study on Aspilia pluriseta against prostate cancer. BMC Complementary Medicine and Therapies (2024).
  3. Application of Hybridization Chain Reaction/CRISPR-Cas12a for the Detection of SARS-CoV-2 Infection. Diagnostics (2023).
  4. Evaluation of lethality and cytotoxic effects induced by Naja ashei venom and efficacy of selected antivenoms in Kenya. Toxicon: X (2022).
  5. Development and Characterization of Anti-Naja ashei Three-Finger Toxins-Specific Monoclonal Antibodies. Toxins (2022).

Research Impact

The scientific impact of Cleophas Mutinda Kyama’s work is reflected through citation metrics, interdisciplinary collaborations, and practical biomedical applications. His investigations into molecular diagnostics and therapeutic evaluation contribute to contemporary discussions surrounding affordable healthcare technologies, precision diagnostics, and evidence-based medicinal research.[4]

Research involving CRISPR-based diagnostics and nanoparticle-assisted detection systems demonstrates alignment with emerging biomedical technologies that support rapid pathogen identification and translational healthcare innovation.[8] Similarly, his toxicological and antivenom studies address healthcare concerns related to snakebite management in endemic regions.

The integration of phytomedicine, computational molecular analysis, and laboratory validation techniques further reflects a multidisciplinary scientific framework capable of supporting future biomedical innovation and collaborative translational research initiatives.[3]

Award Suitability

The scholarly profile of Cleophas Mutinda Kyama demonstrates characteristics associated with international academic recognition and research excellence awards. His documented publication history, citation impact, interdisciplinary biomedical investigations, and sustained engagement in translational health sciences collectively support recognition within the framework of the Global Innovation Technologist Awards.[1]

  • Demonstrated publication productivity in indexed scientific journals.
  • Strong citation impact and measurable academic influence.
  • Contributions to molecular diagnostics and translational medicine.
  • Interdisciplinary biomedical innovation relevant to public health.
  • Research engagement involving computational and experimental methodologies.

Conclusion

Cleophas Mutinda Kyama has established a research profile characterized by interdisciplinary biomedical inquiry, molecular diagnostic innovation, and translational scientific investigations addressing major health challenges. His academic contributions in oncology, toxicology, molecular biology, and infectious disease diagnostics demonstrate sustained scholarly engagement and measurable scientific impact.[5] Through collaborative biomedical research and publication activity, his work contributes to evolving scientific understanding within medicine and health sciences while supporting broader healthcare research objectives relevant to emerging global health priorities.

References

  1. Elsevier. (n.d.). Scopus author details: Cleophas Mutinda Kyama, Author ID 57216717397. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57216717397
  2. Kyama, C. M. et al. (2025). Computational investigation and experimental validation of the molecular mechanism of Solanecio mannii aqueous roots extract against cervical cancer. PLOS ONE.
    https://doi.org/10.1371/journal.pone.0323680
  3. Kyama, C. M. et al. (2024). Network pharmacology, molecular docking, and in vitro study on Aspilia pluriseta against prostate cancer. BMC Complementary Medicine and Therapies.
    https://doi.org/10.1186/s12906-024-04642-8
  4. Kyama, C. M. et al. (2023). Application of Hybridization Chain Reaction/CRISPR-Cas12a for the Detection of SARS-CoV-2 Infection. Diagnostics.
    https://doi.org/10.3390/diagnostics13091644
  5. Jomo Kenyatta University of Agriculture and Technology. (n.d.). Medical Laboratory Sciences and Biomedical Research Activities.
  6. Kyama, C. M. et al. (2022). Expression of the Fab enzymes from Plasmodium falciparum after exposure to Artemisia afra plant extracts. Journal of Parasitic Diseases.
    https://doi.org/10.1007/s12639-022-01537-8
  7. Kyama, C. M. et al. (2022). Development and Characterization of Anti-Naja ashei Three-Finger Toxins-Specific Monoclonal Antibodies. Toxins.
    https://doi.org/10.3390/toxins14040285
  8. Kyama, C. M. et al. (2020). Development of HPV 16/18 E6 oncoprotein paper-based nanokit for enhanced cervical cancer screening.
    https://doi.org/10.1101/2020.04.29.20084459

Tadesse Tarik Tamir | Medicine | Editorial Board Member

Published on by Innovation Technologist

Mr. Tadesse Tarik Tamir | Medicine | Editorial Board Member

Senior Lecturer at College of Medicine and Health Sciences, University of Gondar | Ethiopia

Mr. Tadesse Tarik Tamir is a dedicated scholar and lecturer in Pediatrics and Child Health Nursing at the University of Gondar, Ethiopia, with a strong research footprint in maternal and child health. He has authored more than 65 peer-reviewed publications, contributing extensively to areas such as neonatal and infant mortality, childhood nutrition, immunization coverage, maternal vaccination, and pediatric mental health. His work is characterized by rigorous analytical approaches, including spatial, multilevel, and hierarchical modeling applied to large demographic and health survey datasets across Africa. Tadesse’s research offers critical insights into public health challenges affecting vulnerable populations, particularly mothers, infants, and young children in low- and middle-income settings. In addition to his academic role, he actively supports knowledge generation through teaching and community engagement, fostering a supportive environment for emerging researchers. Currently advancing his expertise through studies in epidemiology, he demonstrates a strong commitment to evidence-based practice and interdisciplinary collaboration. His contributions continue to inform policy, improve health service delivery, and shape interventions aimed at reducing preventable morbidity and mortality among children and women across sub-Saharan Africa.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Tamir, T. T., Zegeye, A. F., Workneh, B. S., Ali, M. S., Gonete, A. T., Techane, M. A., Wassie, M., Kassie, A. T., Ahmed, M. A., & Tsega, S. S., et al. (2025). Childhood wasting and associated factors in Africa: Evidence from standard demographic and health surveys from 35 countries. BMC Public Health.

Tamir, T. T., Tekeba, B., Techane, M. A., Alemu, T. G., Wubneh, C. A., & Wassie, Y. A. (2025). Coverage of complete basic childhood vaccination and its variation by basic characteristics among children aged 12–23 months in 41 low- and middle-income countries: A meta-analysis of demographic and health survey reports between 2015 and 2025. Vaccine.

Kassie, A. T., Zegeye, A. F., Bazezew, A. M., Mamo, E. Y., Gebru, D. M., & Tamir, T. T. (2025). Determinants of pressure to conceive among reproductive age women in sub-Saharan Africa: A multilevel analysis of recent demographic and health surveys in five countries. PLOS Global Public Health.

Mekonen, E. G., Workneh, B. S., Zegeye, A. F., & Tamir, T. T. (2025). Only three out of ten women received adequate postnatal care in sub-Saharan Africa: Evidence from 20 countries demographic and health surveys (2015–2022). BMC Pregnancy and Childbirth.

Tekeba, B., Tamir, T. T., & Zegeye, A. F. (2025). Prevalence and determinants of full vaccination coverage according to the national schedule among children aged 12–35 months in Ghana. Scientific Reports.